Hologic

Health Care Health Care Equipment Marlborough, Massachusetts Last filing Nov 18, 2025 · FY2025

                    Revenue
                    FY2025
                
$4.1B
                    3y CAGR -5.5%
                    
                    P6
                    
                    +1.7%
                    
                    Net income
                    FY2025
                
$565.7M
                    Net margin +13.8%
                    
                    P55
                    
                    -28.3%
                    
                    Total assets
                    FY2025
                
$9.0B
                    ROA +6.3%
                    
                    P55
                    
                    -1.5%
                    
                    Operating cash flow
                    FY2025
                
$1.1B
                    FCF margin +22.4%
                    
                    P80
                    
                    -17.7%

19 yrs · FY2007–FY2025 8 filed · 1 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

30 accounts · 10 years

Total assets $9.0B

Total liabilities ~$4.0B

Shareholders equity $5.0B

Account	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Assets
Cash and Cash Equivalents	47.8%	53.6%	67.5%	—	—	18.6%	17.9%	20.7%	17.7%	19.4%
Short Term Investments	5.9%	4.3%	0.0%	—	—	—	—	—	—	—
Accounts Receivable	14.7%	14.9%	15.5%	12.7%	16.7%	27.2%	19.3%	18.0%	17.4%	15.8%
Inventory	16.6%	16.9%	15.3%	12.8%	8.9%	10.5%	13.2%	11.9%	10.8%	9.7%
Prepaid Expenses	4.5%	5.2%	5.1%	5.8%	9.8%	2.6%	2.9%	2.9%	2.4%	2.0%
Total Current Assets	89.5%	94.9%	103.8%	79.4%	56.3%	58.8%	53.3%	53.6%	48.3%	46.8%
Property,Plant and Equipment	13.6%	13.3%	12.8%	9.9%	10.0%	13.0%	14.0%	14.9%	15.5%	16.2%
Goodwill	88.8%	85.4%	81.4%	66.6%	58.3%	70.4%	76.1%	78.7%	103.7%	99.0%
Intangible Assets	14.4%	21.0%	22.0%	26.3%	29.5%	34.6%	43.4%	74.5%	90.6%	93.3%
Long Term Investments	0.0%	2.4%	0.0%	—	—	—	—	—	—	—
Other Noncurrent Assets	13.6%	10.2%	6.6%	4.3%	4.4%	13.7%	4.6%	3.0%	2.8%	3.0%
Total Assets	219.8%	227.2%	226.8%	186.5%	158.4%	190.5%	191.3%	224.7%	260.9%	258.3%
Liabilities
Accounts Payable	4.7%	5.1%	4.3%	4.1%	3.8%	4.7%	5.5%	6.0%	5.4%	5.5%
Accrued Liabilities	14.1%	14.4%	13.3%	11.0%	10.6%	14.5%	12.8%	13.6%	12.3%	10.2%
Deferred Revenue	4.9%	5.3%	4.9%	3.8%	3.5%	4.9%	5.3%	5.4%	5.6%	5.7%
Current Portion of Long Term Debt	0.1%	0.9%	7.1%	0.3%	5.6%	8.6%	8.1%	18.6%	37.6%	10.4%
Other Current Liabilities	0.1%	0.1%	0.3%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.0%
Total Current Liabilities	23.8%	25.7%	30.0%	19.3%	23.6%	32.8%	31.8%	43.6%	61.0%	31.8%
Long Term Debt	61.1%	62.0%	62.8%	57.8%	48.2%	71.9%	82.7%	84.0%	71.0%	107.6%
Deferred Revenue Noncurrent	0.3%	0.3%	0.3%	0.2%	0.4%	0.3%	0.5%	0.6%	0.7%	0.6%
Deferred Tax Liabilities	1.1%	1.5%	0.5%	1.9%	4.4%	5.3%	8.2%	15.5%	31.8%	34.7%
Other Noncurrent Liabilities	10.5%	10.4%	8.7%	7.2%	7.0%	8.5%	5.4%	5.5%	5.3%	7.9%
Equity
Preferred Stock	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Common Stock	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%
Additional Paid In Capital	154.7%	154.9%	152.4%	124.3%	105.9%	156.4%	171.3%	176.2%	184.1%	196.3%
Retained Earnings	83.2%	70.6%	51.0%	32.9%	5.3%	-41.7%	-79.8%	-77.5%	-77.9%	-110.8%
Treasury Stock	112.5%	95.6%	75.3%	52.1%	35.3%	41.8%	27.5%	22.6%	14.7%	8.8%
Accumulated Other Comprehensive Income	-2.5%	-2.8%	-3.7%	-4.9%	-1.0%	-1.3%	-1.3%	-0.8%	-0.5%	-1.1%
Total Stockholders Equity	123.1%	127.3%	124.5%	100.3%	74.9%	71.6%	62.8%	75.5%	91.0%	75.6%
Total Liabilitiesand Equity	219.8%	227.2%	226.8%	186.5%	158.4%	190.5%	191.3%	224.7%	260.9%	258.3%

Income Statement

Revenue, expense, and profitability

19 accounts · 10 years

Revenue $4.1B

Operating income $714.3M

Net income $565.7M

Account	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
IncomeStatement
Revenues Total Revenue	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%
Other Income Expense Gross Profit	51.6%	55.3%	51.4%	61.6%	67.4%	59.0%	34.8%	52.7%	53.0%	55.2%
Expenses Research and Development	6.1%	6.8%	7.3%	5.8%	4.9%	5.9%	6.9%	6.8%	7.6%	8.2%
Expenses Selling,General and Administrative	26.1%	24.7%	24.5%	21.3%	17.7%	22.3%	26.6%	28.3%	27.5%	24.1%
Expenses Depreciation and Amortization	0.4%	0.7%	0.7%	0.9%	0.7%	1.1%	1.5%	1.8%	9.7%	10.4%
Expenses Restructuring and Asset Impairment	1.7%	1.2%	1.4%	0.6%	0.2%	0.5%	3.4%	23.2%	0.4%	0.4%
Expenses Other Operating Expenses	8.8%	5.5%	10.5%	5.6%	4.8%	7.4%	26.6%	9.9%	-27.4%	3.2%
Expenses Operating Expenses	34.2%	33.4%	34.8%	27.9%	23.4%	29.7%	38.4%	60.1%	8.2%	35.8%
Other Income Expense Operating Income	17.4%	21.9%	16.6%	33.7%	44.0%	29.3%	-3.7%	-7.4%	44.8%	19.4%
Other Income Expense Interest Income	1.8%	2.7%	3.0%	0.3%	0.0%	0.1%	0.1%	0.2%	0.1%	0.0%
Other Income Expense Interest Expense	2.9%	3.0%	2.8%	2.0%	1.7%	3.1%	4.2%	4.6%	5.0%	5.5%
Other Income Expense Other Income/expense	0.2%	-0.1%	-0.0%	0.6%	-0.5%	0.2%	0.1%	-1.2%	0.3%	0.8%
Other Income Expense Income Before Tax	16.6%	21.5%	16.8%	32.7%	41.9%	26.5%	-7.7%	-13.0%	40.2%	14.7%
Income Tax Income Tax Expense	2.8%	1.9%	5.5%	5.9%	8.7%	-2.9%	-1.6%	-9.5%	15.5%	3.0%
net Income net Income	13.8%	19.6%	11.3%	26.8%	33.2%	29.5%	-6.0%	-3.5%	24.7%	11.7%
net Income Comprehensive Income	14.1%	20.5%	13.6%	23.1%	33.1%	29.2%	-6.5%	-3.7%	25.2%	11.0%
Earnings Per Share Basic Eps	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	-0.0%	-0.0%	0.0%	0.0%
Earnings Per Share Diluted Eps	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	-0.0%	-0.0%	0.0%	0.0%
Earnings Per Share Weighted Average Shares Diluted	5.5%	5.9%	6.2%	5.2%	4.6%	7.0%	8.0%	8.5%	9.3%	10.1%

Cash Flow Statement

Operating, investing, and financing flows

22 accounts · 10 years

Operating cash flow $1.1B

Investing cash flow $-482.7M

Financing cash flow $-777.2M

Account	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
CashFlow
Operating Activities net Income	13.8%	19.6%	11.3%	26.8%	33.2%	29.4%	-6.0%	-3.5%	24.7%	11.7%
Operating Activities Depreciation and Amortization	7.3%	7.7%	8.0%	8.8%	7.2%	10.0%	13.8%	14.9%	14.7%	16.4%
Operating Activities Stock Based Compensation	2.1%	2.0%	2.0%	1.4%	1.2%	2.2%	1.8%	2.0%	2.2%	2.3%
Operating Activities Deferred Income Taxes	-3.5%	-1.8%	-2.7%	-3.4%	-1.2%	-2.5%	-7.0%	-14.8%	-11.7%	-5.5%
Operating Activities Changes In Operating Assets and Liabilities	-0.5%	2.1%	0.3%	9.3%	0.2%	-16.8%	-4.6%	-0.8%	-3.4%	2.0%
Operating Activities Other Non Cash Items	6.6%	2.3%	7.2%	0.8%	0.8%	1.5%	21.4%	24.9%	-26.3%	1.3%
Operating Activities net Cash From Operating Activities	25.8%	31.9%	26.1%	43.7%	41.4%	23.7%	19.3%	22.8%	0.3%	28.2%
Investing Activities Capital Expenditures	-3.3%	-3.2%	-3.7%	-2.6%	-3.2%	-4.1%	-3.2%	-3.3%	-3.5%	-3.3%
Investing Activities Business Acquisitions	-7.8%	-8.2%	-0.1%	-3.3%	-20.7%	0.5%	-3.3%	-2.4%	10.0%	0.0%
Investing Activities Purchases of Investments	-4.4%	-7.7%	-0.2%	0.0%	0.0%	—	-0.5%	-0.2%	0.0%	0.0%
Investing Activities Proceeds From Sale of Investments	4.3%	0.0%	0.0%	—	—	—	—	—	2.8%	1.3%
Investing Activities Other Investing Activities	-0.4%	-0.3%	0.3%	1.6%	0.2%	-0.1%	-1.3%	-0.2%	-0.0%	-0.4%
Investing Activities net Cash From Investing Activities	-11.8%	-19.4%	-3.8%	-4.2%	-23.6%	-3.7%	-8.3%	-6.1%	9.3%	-2.4%
Financing Activities Proceeds From Debt	28.3%	0.0%	0.0%	30.7%	16.6%	19.9%	58.7%	124.3%	11.3%	1.8%
Financing Activities Repayment of Debt	-29.2%	-7.1%	-0.4%	-29.8%	-23.0%	-14.5%	-66.7%	-128.7%	-15.7%	-24.5%
Financing Activities Repurchase of Common Stock	-18.4%	-20.7%	-11.8%	-11.1%	-7.3%	-17.3%	-5.9%	-8.6%	-6.5%	-8.8%
Financing Activities Proceeds From Stock Issuance	0.9%	0.9%	1.1%	0.7%	0.9%	1.7%	1.5%	1.0%	1.6%	1.4%
Financing Activities Tax Withholding On Stock Based Compensation	-0.5%	-0.4%	-0.6%	-0.5%	-0.8%	-0.4%	-0.4%	-0.5%	-0.6%	-0.6%
Financing Activities Other Financing Activities	-0.1%	-0.2%	-0.3%	-5.4%	4.2%	-6.9%	-0.0%	-0.1%	-0.1%	7.1%
Financing Activities net Cash From Financing Activities	-19.0%	-27.5%	-12.0%	-15.5%	-9.4%	-17.5%	-12.8%	-12.6%	-10.1%	-23.7%
Cash Reconciliation Effect of Exchange Rate On Cash	0.1%	0.2%	0.0%	0.1%	-0.0%	0.1%	-0.1%	-0.2%	0.2%	-0.1%
Cash Reconciliation net Change In Cash	-4.9%	-14.8%	10.3%	24.0%	8.3%	2.6%	-1.9%	3.9%	-0.3%	2.0%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 10 years

Ratio	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Profitability
Gross margin	—	—	—	—	—	—	—	—	—	+73.3%
Operating margin	+17.4%	+21.9%	+16.6%	+33.7%	+44.0%	+29.3%	-3.7%	-7.4%	+44.8%	+19.4%
Net margin	+13.8%	+19.6%	+11.3%	+26.8%	+33.2%	+29.5%	-6.0%	-3.5%	+24.7%	+11.7%
FCF margin	+22.4%	+28.7%	+22.4%	+41.1%	+38.2%	+19.6%	+16.0%	+19.5%	-3.2%	+24.8%
Growth
Revenue CAGR (3y)	-5.5%	-10.6%	+2.2%	+13.0%	+20.5%	+7.3%	+5.9%	+6.0%	+6.5%	+4.4%
Returns
ROE	+11.2%	+15.4%	+9.1%	+26.7%	+44.4%	+41.2%	-9.6%	-4.6%	+27.1%	+15.4%
ROA	+6.3%	+8.6%	+5.0%	+14.4%	+21.0%	+15.5%	-3.2%	-1.5%	+9.5%	+4.5%
ROIC	+10.6%	+14.6%	+8.8%	—	—	+21.9%	-2.7%	-4.7%	+15.1%	+8.8%
Liquidity
Current ratio	3.75x	3.69x	3.47x	4.12x	2.39x	1.79x	1.68x	1.23x	0.79x	1.47x
Quick ratio	2.62x	2.66x	2.77x	—	—	1.40x	1.17x	0.89x	0.58x	1.10x
Leverage
D/E	0.79x	0.78x	0.82x	0.86x	1.11x	1.66x	2.04x	1.98x	1.87x	2.41x
Interest coverage	6.10x	7.23x	6.02x	17.25x	26.50x	9.48x	-0.88x	-1.60x	8.94x	3.53x
Efficiency
Asset turnover	0.45x	0.44x	0.44x	0.54x	0.63x	0.52x	0.52x	0.45x	0.38x	0.39x
Cash conversion cycle	—	—	—	—	—	—	—	—	—	+114d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched

Hologic

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Recent price history